Dakota Wealth Management lessened its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 13.4% in the fourth quarter, HoldingsChannel.com reports. The firm owned 11,896 shares of the company’s stock after selling 1,843 shares during the quarter. Dakota Wealth Management’s holdings in Clorox were worth $1,932,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Brooklyn Investment Group grew its position in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new stake in shares of Clorox during the 3rd quarter worth approximately $27,000. Continuum Advisory LLC grew its position in shares of Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after buying an additional 138 shares during the period. Quarry LP grew its position in shares of Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after buying an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC acquired a new stake in shares of Clorox during the 3rd quarter worth approximately $48,000. Institutional investors and hedge funds own 78.53% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts have recently commented on CLX shares. Evercore ISI reduced their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and increased their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. DA Davidson increased their target price on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Finally, Barclays cut their target price on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a report on Friday, January 17th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $156.54.
Clorox Price Performance
Shares of NYSE:CLX opened at $160.81 on Friday. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The stock’s fifty day simple moving average is $163.93 and its two-hundred day simple moving average is $157.11. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The stock has a market cap of $19.90 billion, a PE ratio of 56.03, a price-to-earnings-growth ratio of 2.95 and a beta of 0.42.
Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.49 EPS. As a group, analysts forecast that The Clorox Company will post 6.87 EPS for the current fiscal year.
Clorox Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.03%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s payout ratio is 170.04%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- 3 Warren Buffett Stocks to Buy Now
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- 3 Tickers Leading a Meme Stock Revival
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- What is the S&P/TSX Index?
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.